SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-155941
Filing Date
2020-05-29
Accepted
2020-05-29 17:12:07
Documents
7
Period of Report
2020-05-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d937881d8k.htm 8-K 40575
2 EX-2.1 d937881dex21.htm EX-2.1 130149
3 EX-10.1 d937881dex101.htm EX-10.1 98192
4 EX-10.2 d937881dex102.htm EX-10.2 23597
5 EX-10.3 d937881dex103.htm EX-10.3 15001
6 EX-99.1 d937881dex991.htm EX-99.1 17445
7 GRAPHIC g937881g81p34.jpg GRAPHIC 15584
  Complete submission text file 0001193125-20-155941.txt   347702
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35068 | Film No.: 20929195
SIC: 2834 Pharmaceutical Preparations